1-16052300-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_000085.5(CLCNKB):c.1511C>T(p.Ala504Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000961 in 1,613,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A504A) has been classified as Likely benign.
Frequency
Consequence
NM_000085.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCNKB | NM_000085.5 | c.1511C>T | p.Ala504Val | missense_variant | 15/20 | ENST00000375679.9 | NP_000076.2 | |
CLCNKB | NM_001165945.2 | c.1004C>T | p.Ala335Val | missense_variant | 8/13 | NP_001159417.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCNKB | ENST00000375679.9 | c.1511C>T | p.Ala504Val | missense_variant | 15/20 | 1 | NM_000085.5 | ENSP00000364831.5 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000680 AC: 17AN: 249884Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135556
GnomAD4 exome AF: 0.0000979 AC: 143AN: 1460868Hom.: 0 Cov.: 36 AF XY: 0.0000936 AC XY: 68AN XY: 726754
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 12, 2016 | - - |
Bartter disease type 3;C4310805:Bartter disease type 4B Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 01, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 05, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 504 of the CLCNKB protein (p.Ala504Val). This variant is present in population databases (rs371971275, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CLCNKB-related conditions. ClinVar contains an entry for this variant (Variation ID: 447092). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCNKB protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at